Abstract. Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) function to remodel the pericellular environment. We have investigated the role of the MMP / TIMP system in methamphetamine (METH) dependence in rodents, in which the remodeling of neural circuits may be crucial. Repeated METH treatment induced behavioral sensitization, which was accompanied by an increase in MMP-2 / -9 / TIMP-2 activity in the brain. An antisense TIMP-2 oligonucleotide enhanced the sensitization, which was associated with a potentiation of the METH-induced release of dopamine in the nucleus accumbens (NAc). MMP-2 / -9 inhibitors blocked the METH-induced behavioral sensitization and conditioned place preference (CPP), a measure of the rewarding effect of a drug, and reduced the METH-increased dopamine release in the NAc. In MMP-2-and MMP-9-deficient mice, METH-induced behavioral sensitization and CPP as well as dopamine release were attenuated. The MMP / TIMP system may be involved in METH-induced sensitization and reward by regulating extracellular dopamine levels.
Introduction
Drug dependence is a complex phenomenon with important psychological and social causes and consequences, which may be associated with neural plasticity and the remodeling of specific brain circuits caused by repeated exposure to drugs of abuse (1 -3) . Methamphetamine (METH), a common drug of abuse, has both acute and long-lasting effects on psychomotor behavior (4 -6) . These effects of METH are associated with an increase in extracellular dopamine levels in the brain, achieved by facilitating the release of dopamine from presynaptic nerve terminals and inhibiting its reuptake (7) . It has been proposed that cellular and molecular mechanisms for drug dependence involve processes similar to those operating in other forms of synaptic plasticity such as learning and memory (1, 8) . Although it has been demonstrated that repeated treatment with cocaine and amphetamine produces changes in neural morphology and synaptic connectivity in the mesolimbic system (9, 10) , the mechanism underlying psychostimulant-induced remodeling of synaptic structures remains to be determined (11, 12) .
In order to elucidate the mechanisms by which chronic drug exposure causes stable changes in the brain that may underlie the long-lasting behavioral abnormalities in dependent subjects, we compared the gene expression in the brains of rats that had previously received repeated morphine or METH treatment (12) . We hypothesized that those genes whose expression was altered by repeated administration of morphine and METH could be candidates for drug-dependencerelated genes. We used DNA microarray technology to profile the gene expression in the brains of drugdependent animals. Since we hypothesized that the development of drug dependence is associated with activity-dependent synaptic plasticity and remodeling of the mesocorticolimbic dopaminergic system, we focused on the role of candidate genes found by the DNA microarray screening, especially in relation to cytokines / neurotrophic factor and extracellular matrix / proteases. As a result, we have demonstrated that tumor necrosis factor-α (TNF-α) (7, 11, 13) , tissue plasminogen activator (tPA) (14 -16) , neuroglycan C (17), and matrix metalloproteinase (MMP) (18, 19) were involved in drug dependence.
In this review, we discuss a possible role for the / tissue inhibitor of MMP (TIMP) system in METH dependence.
MMP / TIMP system
MMPs function to remodel the pericellular environment, primarily through the cleavage of extracellular matrix (ECM) proteins (20) . MMPs constitute a family of enzymes with more than 20 members identified to date, which require Zn 2+ for their enzymatic activity. Several MMPs have a furin motif (MMP-11,-14, -15, -16, etc.) that allows for intracellular activation of the proteinase prior to its appearance on the outside of the cell, including all of the membrane-anchored members. Activation of the remaining MMPs requires extracellular proteolytic processing of the secreted zymogen into a fully active enzyme, which can be done by MMPs or some serine proteinases (21) . Interestingly, the tPA/ plasmin system is one of the regulators of MMP (22) and could play a pivotal role in degradation of the ECM (23) . TNF-α can induce the expression of MMPs while MMPs also induce the activation and release of this cytokine.
MMP activity is regulated by interaction with TIMPs. TIMPs belong to a family of multifunctional secreted proteins (TIMP-1 -4) and possess growth-promoting and cell cycle-regulating activities in various cell types (24) . MMP and TIMP function to modulate functional and structural remodeling of the cellular architecture in the context of pathophysiology primarily through the cleavage of ECM proteins, bioavailability of growth factors and cytokines, and shedding of membrane receptors (20, 25) . It has been recently demonstrated that neuronal TIMP-1 (26) and MMP-9 (27) are regulated by synaptic activity, suggesting that the balance between MMPs and TIMPs is important in the activity-dependent re-organization of the neuronal architecture with possible effects on synaptic physiology. Thus, the MMP/ TIMP ratio and net MMP activity may be involved in brain development because extensive cellular migration and remodeling of the ECM are necessary for neural development (22, 28) . A precise knowledge of the relative role of the major MMPs and TIMPs may be indispensable to delineate the mechanisms of brain development and remodeling as well as synaptic plasticity.
Changes in the expression of MMP-2, MMP-9, and TIMP-2 in the brain induced by METH Gelatinases (MMP-2 and MMP-9) are capable of cleaving collagen IV and V, laminin, and chondroitin sulfate proteoglycan, which are associated with cell adhesion, and have been implicated specifically in cerebral ischemia (29) , kainate-induced neuronal injuries (27) , and hippocampal long-term potentiation (LTP) and memory (30) . For example, MMP-2 plays a principal role in establishing the growth-promoting properties of denervated peripheral nerve (31) . MMP-9, but not MMP-2, is particularly involved in dendritic remodeling in the hippocampus of adult rat (27) .
We have demonstrated for the first time that repeated administration of METH leads to behavioral sensitization that is accompanied by the induction of MMP-2, MMP-9, and TIMP-2 expression in the brain including the frontal cortex (Fc) and nucleus acumbens (NAc) ( Table 1) (18, 19) . Our data also showed that MMP-2 and MMP-9 were expressed in neurons as well as glial cells. Repeated, but not single, METH treatment also induced TIMP-2 mRNA and protein expression, and the TIMP-2 was expressed in neurons (19) . Some previous studies suggested that the MMP/ TIMP system is expressed in neuronal and glial cells and that the expression level and cellular localization may be regulated according to the developmental and / or functional status of the brain (27, 28) . For instance, during the process of axonal extension, MMP is located at the growth cone tips, permitting attachment / detachment between the neurons and matrix substratum (32) , and oligodendrocytes utilize MMPs to extend their processes (33) , suggesting that the regulation of MMPs is likely to provide guidance during the proliferation of new synapses. Accordingly, it is plausible that MMP-2 and MMP-9 take part in the structural and functional alterations in the brain following repeated exposure to METH.
Role of the MMP/ TIMP system in METH-induced behavioral sensitization and reward
We demonstrated that METH-induced behavioral sensitization and conditioned place preference (CPP), a measure of the rewarding effect of a drug, were markedly attenuated in MMP-2 homozygous knock-out [MMP-2-(−/ −)] and MMP-9-(−/ −) mice compared with wild-type mice (18) . We found that inhibitors of MMP-2/ -9 blocked the METH-induced behavioral sensitization and CPP (19) . Antisense TIMP-2 oligonucleotide (TIMP-AS) treatment, which inhibited the METH-induced increase in TIMP-2 protein expression, enhanced the sensitization, an effect that was associated with a potentiation of the METH-induced release of dopamine in the NAc (19) . Accordingly, it is suggested that the net increase in MMP activity is responsible at least in part for the development of METH-induced behavioral sensitization, and that the MMP / TIMP imbalance may influence the structural and functional changes in the brain, related to METH dependence. Indeed, the inhibition of MMPs alters functional and structural correlations of deafferentation-induced sprouting such as remodeling in the dentate gyrus of the hippocampus (34) . In a behavioral study, MMP-9 knock-out mice displayed impairments in LTP and hippocampal-dependent memory in a fear-conditioning memory task (30) . Since learning / memory mechanisms are considered to overlap with and are involved in the development of drug dependence that occurs with the chronic administration of drugs of abuse (2, 8) , MMP-2 and MMP-9 expression may play a crucial role in the acquisition of METH-induced CPP. Interestingly, Brown et al. (35) have demonstrated that MMPs were involved in the learning of a cocaine-associated contextural memory and that reconsolidation of this memory was disrupted by an MMP inhibitor. Furthermore, they showed the ability of an MMP inhibitor to impair the expression of memory for a cocaine-associated cue after extinction. Although they did not examine whether MMP activity and expression were increased by cocaine treatment or a cocaine-associated stimulus, MMPs may also have a crucial role in drug-associated memory.
Role of the MMP / TIMP system in dopamine neurotransmission
Behavioral changes induced by METH are linked to its capacity to elevate extracellular dopamine levels through the redistribution of dopamine from synaptic vesicles to the cytosol and promotion of reverse transport (7, 36) . METH-induced behavioral sensitization is associated with an enhancement of the METHinduced increase in extracellular dopamine levels in the NAc (7, 15) . In the MMP-2-(−/ −) and MMP-9-(−/ −) mice compared with the wild-type mice, METHincreased dopamine release in the NAc as well as METH-induced behavioral sensitization and CPP were attenuated. TIMP-AS treatment enhanced the sensitization of METH-induced dopamine release in the NAc, while MMP-2 / -9 inhibitors reduced it. In contrast, infusion of purified human MMP-2 into the NAc significantly potentiated the METH-increased dopamine release. The uptake of [
3 H]dopamine into striatal synaptosomes was reduced in wild-type mice after repeated METH treatment, and the changes in [ 3 H]dopamine uptake were significantly attenuated in MMP-2-(−/ −) and MMP-9-(−/ −) mice (18) . It has been demonstrated that the reverse activation and internalization of plasmalemmal dopamine transporter (DAT) are involved in the METH-induced increase in extracellular dopamine levels (36, 37) . These results suggest that both MMP-2 and MMP-9 play a crucial role in METHinduced behavioral sensitization and reward by regulating METH-induced dopamine release and uptake via DAT in the NAc.
The sensitivity of dopamine receptors to endogenous and exogenous ligands is important for dopamine neurotransmission in physiology and pathology. Reduced signaling via Gi-coupled receptors may be an important neuroadaptation in cocaine addiction (38) . G protein signaling in the Fc plays a crucial role as a potential pathological change contributing to cocaine sensitization and drug seeking (39) . In fact, we also have shown that dopamine receptor agonist-stimulated (19) . These results suggest that the MMP / TIMP system is involved in the METH-induced dysregulation of dopamine release and receptor signaling. As dopamine D 2 receptors function in the feedback inhibition of dopamine release (40, 41) , the downregulation may contribute to an enhancement of the METHinduced increase in extracellular dopamine levels. Recently, Kim et al. (42) have demonstrated that MMP-3 has a specific role in dopamine neuronal degeneration. They suggested that the active MMP-3 released from stressed dopamine neurons is a candidate molecule that activates microglia, leads to production of superoxide, and plays a pivotal role in dopamine neuronal death, and they proposed that abrogation of MMP-3 or inhibition of MMP-3 activity in early neuronal degeneration may be an effective means of preventing progressive degeneration of dopamine neurons. This study strongly suggests that MMPs play a crucial role in the regulation of dopaminergic neurons in various diseases.
Conclusion
As reviewed in this article, MMP-2, MMP-9, and TIMP-2 are involved in the rearrangement of the neural network in the mesocorticolimbic dopamine system, which plays a crucial role in the development of behavioral sensitization to METH (Table 2 ). It is likely that the MMP / TIMP system plays a role in METHinduced behavioral sensitization through modulation of the function of plasma membrane proteins such as dopamine receptors and transporters. These results, together with the fact that MMP acts to degrade components of the ECM such as laminin and collagen IV, suggest that repeated METH-induced overexpression of MMP-2, MMP-9, and TIMP-2 is associated with the structural and functional changes in the mesocorticolimbic dopamine system, leading to METH-induced behavioral sensitization and reward following repeated drug treatment. We have proposed that some cytokines and neurotrophic factors such as basic fibroblast growth factor and brain-derived neurotrophic factor act as pro-addictive cytokines, whereas glia-derived neurotrophic factor and TNF-α act as antiaddictive cytokines, which reduce the rewarding effects of drugs of abuse (11) . It appears that MMP-2 and MMP-9 can be classified as pro-addictive, whereas TIMP-2 may be anti-addictive. We propose that the dynamic changes to, and balance of, levels of pro-addictive and anti-addictive factors in the brain are determinants of susceptibility to drug dependence. Furthermore, our findings suggest that inhibitions of pro-addictive factors such as MMP-2 and MMP-9 may be effective in the treatment of drug dependence. 
